The FDA Will Soon Give These 3 Healthcare Companies the Green Light

Novavax ( NVAX -4.41% ) has a vaccine for COVID-19 with fantastic phase 3 data, and the company is waiting to hear about its Emergency Use Authorization (EUA) from U.S. regulators. Axsome Therapeutics ( AXSM -1.26% ) has two FDA filings in the hopper, and hopes to have both drugs approved this year. And Novocure ( NVCR -5.31% ) is close to the finish line in submitting data for using tumor-treating fields to stop lung cancer. Here's why these investors are bullish on these three stocks in 2022.